|
Today, about 135 million people around the world have diabetes. According to the World Health Organisation (WHO), ten years from now the number will have grown to more than 200 million. Furthermore, it is estimated that approximately 70% of people with diabetes worldwide are not in full compliance with the guidelines for managing their disease. This causes complications and unnecessary suffering.
An estimated 80% of a given country's health care budget for diabetes is spent on people who have been admitted to hospital in order to treat complications. The million dollar question is, if this money is being spent in the right way to fight the burden of diabetes. This question is especially pertinent in countries with a limited budget for national health. Instead, could it be possible to develop an approach that saves both suffering and money in the long run?
Novo Nordisk's disease management concept builds on the idea that educating people with diabetes about their disease will help them control it and avoid many complications. Gaining control over the disease is a difficult process which often involves a change of lifestyle, namely diet and physical fitness. However, the benefits are well worth the efforts.
Dual purpose The Novo Nordisk approach stresses prevention of complications in preference to treatment alone. The aim is to reduce the need for hospitalisation by preventing complications.
There is of course a marketing purpose as well. Our disease management activities aim to strengthen the partnership with local officials and doctors, thereby creating a preference for Novo Nordisk's products and services. Our approach therefore combines two goals: it is not only better for business but also for society, which adds up to a sustainable solution.
The Bulgarian Education Project The Bulgarian Education Project is an example of how Novo Nordisk works with disease management in practice. The programme aims at enhancing the education of people with diabetes in Bulgaria. Approximately 175,000 people in Bulgaria have diabetes, and the number is increasing. Historically, the Bulgarian health system has focused primarily on treatment and not prevention.
In early 1997, it was decided to carry out a joint project between the Danish Ministry of Foreign Affairs, the Bulgarian Ministry of Health and Novo Nordisk. We have great expertise on diabetes and this is a good example of a mutually beneficial partnership between a private company and government authorities. Novo Nordisk manages the project and contributes a team of experts who will spend 3.5 man-years on the project. |